Header Logo

Connection

Yuki Kageyama to Chemoradiotherapy

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Chemoradiotherapy.
Yuki Kageyama
Connection Strength
0.168
Chemoradiotherapy
  1. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 2020 11; 9(22):8355-8363.
    View in: PubMed
    Score: 0.168
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.